American Capital Ltd

American Capital — Merger or Acquisition (November 2016)

16 slides from American Capital's merger presentation, Nov 22, 2016

  1. Slide 1: Disclaimer

    Disclaimer The following slides contain “forward-looking” statements as that term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995, including statements rega

  2. Slide 2: Disclaimer

    Disclaimer The following slides contain information in respect of each of ARCC and ACAS. Neither ARCC nor ACAS makes any representation or warranty, express or implied, with respect to the information contained herein (including, without limitation, information obtained from third parties) or the ac

  3. Slide 3: Investment Thesis for Transaction

    Investment Thesis for Transaction We believe this strategic acquisition will enhance ARCC’s position as the largest business development company(1) in the United States and a leading direct lender to U.S. middle market companies We believe that this acquisition will generate value for our stockholde

  4. Slide 4: Total consideration to American Capital shareholders

    American Capital Shareholders will receive approximately $4.0 billion or $17.52** per share of total consideration consisting of: Approximately $1.494 billion, or the sum of $6.41 per share plus certain Ares Capital make-up dividend amounts of $0.07 per share, in cash from Ares Capital Ares Capital

  5. Slide 5: Total Consideration Paid to ACAS Shareholders

    Based on ARCC’s stock price of $15.30 per share as of 10/31/2016 at a fixed exchange ratio of 0.483x. $1.478 billion of cash from ARCC, excluding $16 million make-up dividend. Includes certain Ares Capital make-up dividend amounts of $16 million, assuming closing occurs the first week of January 201

  6. Slide 6: Transaction Updates

    Transaction Updates Significant Progress Made with Asset Monetizations and Realizations and Junior Capital Reduced ACAS Balance Sheet Composition has De-risked with NAV Growth, All Debt Repaid and Cash Increased Significant Progress Toward Closing with Few Remaining Open Items As of 9/30/16. Assumes

  7. Slide 7: Update on ARCC's Performance and Strategy

    Update on ARCC’s Performance and Strategy Since transaction announcement, ARCC has continued to perform well and execute on its strategy in the following ways: 1 Generated strong Q2 and Q3 core EPS of $0.39 per share and $0.43 per share, respectively, both in excess of the $0.38 per share quarterly

  8. Slide 8: Opportunities for Value Creation

    Opportunities for Value Creation Total Investments: $8.8 billion (1) $11.8 billion $3.0 billion (2) We believe that the pro forma portfolio has multiple drivers of potential ROE expansion As of 9/30/2016. As of 9/30/2016, adjusted for actual exits/repayments of ACAS investments between 10/1/2016 and

  9. Slide 9: Pro Forma Company Benefits

    Pro Forma Company Benefits Enhanced Size and Liquidity Diversified Portfolio Potential Catalyst for Dividend Growth Total Equity ($B) Investment Portfolio ($B) (1) ARCC pro-forma shows opportunity for improvement in a number of key areas 215 Portfolio Companies 314 Portfolio Companies Key Drivers of

  10. Slide 10: Conclusion

    Conclusion Since the transaction announcement, ACAS has made significant progress with portfolio monetizations and realizations while increasing its net asset value We expect to meet all closing conditions, subject to ARCC and ACAS stockholder approvals The difference between ARCC stand alone and pr

  11. Slide 11: Conclusion

    Conclusion Since the transaction announcement, ACAS has made significant progress with portfolio monetizations and realizations while increasing its net asset value We expect to meet all closing conditions, subject to ARCC and ACAS stockholder approvals The ACAS balance sheet has been de-risked with

  12. Slide 12: Pro Forma Combined Balance Sheet – 9/30/2016

    Pro Forma Combined Balance Sheet – 9/30/2016 13 ($ in millions, except per share amounts) Actual Ares Capital Adjusted American Capital (A)* Pro Forma Adjustments Ares Capital Pro Forma Combined Assets and Liabilities Data: Investments, at fair value $ 8,805 $ 3,163 $ (167) [B] $ 11,801 Cash and cas

  13. Slide 13: Endnotes

    Endnotes ($ in millions, except per share amounts) To reflect American Capital’s balance sheet as of September 30, 2016, updated for estimated changes subsequent to September 30, 2016: Includes actual exits and repayments of investments occurring between October 1, 2016 and October 31, 2016 of $57 a

  14. Slide 14: Endnotes

    Endnotes ($ in millions, except per share amounts) To reflect the acquisition of American Capital by the issuance of approximately 111.3 million shares of Ares Capital common stock. The table below reflects the allocation of the purchase price on the basis of Ares Capital’s estimate of the fair valu

  15. Slide 15: Endnotes

    Endnotes ($ in millions, except per share amounts) The net assets of the pro forma combined company were decreased for the cash consideration paid by Ares Capital to American Capital stockholders of approximately $6.41 per fully diluted share plus certain Ares Capital dividend makeup amounts of $0.0

  16. Slide 16: Endnotes

    Endnotes (Sinmiions, xcept per share amounts) (C) The net assets ofthe pro forma combined company were decreased for the cash consideration paid by Ares Capital to American Capital stockholders of approximately $6.41 per fully diluted share plus certain Ares Capital dividend makeup amounts of $0.07

American Capital — Merger or Acquisition (November 2016) on 6ix